English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2730]
News [7315]
Articles [297]
Editorials [8]
Conferences [228]
elearning [41]
Radiation-induced cellular changes may mimic cancer recurrence in pap smears
Radiation-induced cellular changes may mimic cancer recurrence in pap smears
Study identifies immune switch critical to autoimmunity and cancer
Study identifies immune switch critical to autoimmunity and cancer
SABCS 2025: Sentinel lymph node biopsy may be safely omitted in some patients with early-stage breast cancer
SABCS 2025: Sentinel lymph node biopsy may be safely omitted in some patients with early-stage breast cancer
SABCS 2025: Breast MRI may be safely omitted from diagnostic workup in certain patients with early-stage, HR-negative breast cancer
SABCS 2025: Breast MRI may be safely omitted from diagnostic workup in certain patients with early-stage, HR...
ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome
ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome
Enhancing breast cancer screening could help save young women’s lives
Enhancing breast cancer screening could help save young women’s lives
Researchers develop ultrasensitive method to detect low-frequency cancer mutations
Researchers develop ultrasensitive method to detect low-frequency cancer mutations
Cancer loses its sense of time to avoid stress responses
Cancer loses its sense of time to avoid stress responses
ASH 2025: Developed antibody boosts immune response against blood cancers and solid cancers
ASH 2025: Developed antibody boosts immune response against blood cancers and solid cancers
ASH 2025: Measurable residual disease shows strong potential as an early indicator of survival in acute myeloid leukaemia
ASH 2025: Measurable residual disease shows strong potential as an early indicator of survival in acute myeloid...
<12345…732>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top